StonvexLoading…
StonvexStonvexStonvexCore line items from TXNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.14B | $1.96B | $1.91B | $2.25B |
Operating Income | $441.18M | $453.49M | $231.34M | $393.76M |
Net Income | $169.83M | $258.72M | $106.88M | $185.18M |
EPS (Diluted) | $1.48 | $2.67 | $1.02 | $1.97 |
Total Assets | $12.06B | $11.21B | $10.25B | $9.26B |
Total Liabilities | $8.60B | $8.62B | $7.84B | $7.00B |
Cash & Equivalents | $18.26M | $4.50M | $2.21M | $4.08M |
Free Cash Flow OCF − CapEx | $-611.43M | $-738.88M | $-524.64M | $-345.27M |
Shares Outstanding | 108.92M | 92.66M | 90.20M | 85.83M |